Lab News
Hexapod personal protective booths cut testing costs for COVID-19
January 19, 2021 -- As the COVID-19 pandemic continues to evolve, hospitals and labs have had to get creative, overcome hurdles, and adapt their practices to perform safer COVID-19 testing. One solution is the Hexapod, which is a personal protective booth that allows healthcare providers to undertake swab testing without physically contacting patients.
Discuss
January 19, 2021 -- As the COVID-19 pandemic continues to evolve, hospitals and labs have had to get creative, overcome hurdles, and adapt their practices to perform safer COVID-19 testing. One solution is the Hexapod, which is a personal protective booth that allows healthcare providers to undertake swab testing without physically contacting patients.
Discuss Ortho files for IPO to sell 70M shares
January 19, 2021 -- Ortho Clinical Diagnostics has filed for an initial public offering (IPO) that aims to sell 70 million shares at a price between $20 and $23 per share. The company's shares will be traded on the Nasdaq stock exchange under the symbol "OCDX."
January 19, 2021 -- Ortho Clinical Diagnostics has filed for an initial public offering (IPO) that aims to sell 70 million shares at a price between $20 and $23 per share. The company's shares will be traded on the Nasdaq stock exchange under the symbol "OCDX."
Quest wins CDC contract to sequence COVID-19 gene variants
January 19, 2021 -- Quest Diagnostics has received a contract from the U.S. Centers for Disease Control and Prevention (CDC) to provide genomic sequencing for a project aimed at identifying new mutations and patterns of transmission of SARS-CoV-2.
January 19, 2021 -- Quest Diagnostics has received a contract from the U.S. Centers for Disease Control and Prevention (CDC) to provide genomic sequencing for a project aimed at identifying new mutations and patterns of transmission of SARS-CoV-2.
Exact Sciences nabs license for TARDIS
January 16, 2021 -- Exact Sciences has acquired a worldwide exclusive license for targeted digital sequencing (TARDIS) technology from the Translational Genomics Research Institute.
January 16, 2021 -- Exact Sciences has acquired a worldwide exclusive license for targeted digital sequencing (TARDIS) technology from the Translational Genomics Research Institute.
Eurofins debuts new SARS-CoV-2 variant assay
January 15, 2021 -- Eurofins has launched a new SARS-CoV-2 assay and increased its capacity to detect and monitor new variants of the novel coronavirus.
January 15, 2021 -- Eurofins has launched a new SARS-CoV-2 assay and increased its capacity to detect and monitor new variants of the novel coronavirus.
DNA testing speeds pneumonia diagnoses in COVID-19 patients
January 15, 2021 -- A new DNA test is helpful for making the diagnosis of secondary pneumonia in COVID-19 patients and treating them accordingly, U.K. researchers reported January 11 in the journal Critical Care.
January 15, 2021 -- A new DNA test is helpful for making the diagnosis of secondary pneumonia in COVID-19 patients and treating them accordingly, U.K. researchers reported January 11 in the journal Critical Care.
ADA lowers optimal blood sugar levels for kids
January 15, 2021 -- The American Diabetes Association (ADA) has issued new guidelines for optimal A1C levels in pediatric patients with type 1 diabetes, lowering them to 7% hemoglobin A1C levels, instead of 7.5%, as per their 2019 guidelines.
January 15, 2021 -- The American Diabetes Association (ADA) has issued new guidelines for optimal A1C levels in pediatric patients with type 1 diabetes, lowering them to 7% hemoglobin A1C levels, instead of 7.5%, as per their 2019 guidelines.
I-calQ receives 9th patent for smartphone POC testing
January 15, 2021 -- Diagnostic developer I-calQ has received a ninth patent for its point-of-care (POC) testing technology, which can be used with most smartphones and can test for potentially hundreds of analytes or agents.
January 15, 2021 -- Diagnostic developer I-calQ has received a ninth patent for its point-of-care (POC) testing technology, which can be used with most smartphones and can test for potentially hundreds of analytes or agents.
Sectra digital pathology goes live in Southern Denmark
January 14, 2021 -- A digital pathology system from Sectra has gone live in the Region of Southern Denmark, connecting lab medicine professionals at four hospitals that are geographically dispersed.
January 14, 2021 -- A digital pathology system from Sectra has gone live in the Region of Southern Denmark, connecting lab medicine professionals at four hospitals that are geographically dispersed.
FDA clears PerkinElmer coronavirus test for asymptomatic use
January 14, 2021 -- PerkinElmer's New Coronavirus Nucleic Acid Detection kit has received an emergency use authorization from the U.S. Food and Drug Administration (FDA) for use in testing people who do not have symptoms of infection and where there is no other reason to suspect a positive result.
January 14, 2021 -- PerkinElmer's New Coronavirus Nucleic Acid Detection kit has received an emergency use authorization from the U.S. Food and Drug Administration (FDA) for use in testing people who do not have symptoms of infection and where there is no other reason to suspect a positive result.
Webinars/Videos
Case Study™
Conferences
Society for Laboratory Automation and Screening (SLAS) 2021
January 23-27
Online
January 23-27
Online
Festival of Genomics & Biodata
January 28-29
Online
January 28-29
Online
A Practical Approach to Surgical Pathology
April 23-25
Las Vegas, Nevada United States
April 23-25
Las Vegas, Nevada United States
International Molecular Pathological Epidemiology (MPE) Meeting
May 24-25
Boston, Massachusetts United States
May 24-25
Boston, Massachusetts United States
European Association for Cancer Research (EACR) Congress
June 9-12
Torino, Piemonte Italy
June 9-12
Torino, Piemonte Italy
Connect
Latest Tweets